Earl Webb Henry
Chief Tech/Sci/R&D Officer at H2O Clinical LLC
Profile
Earl Webb Henry is currently the Director & Chief Medical Officer at Firma Clinical Research LLC and the Chief Medical Officer at H2O Clinical LLC.
He previously worked as an Independent Director at Repligen Corp., Medical Director at HHI Clinical & Statistical Research Services LLC, Senior Associate Director-Clinical Research at Pfizer Central Research, SVP, Head-Clinical Research & Regulatory Affairs at Cephalon, Inc., Vice President-Clinical Research at Guilford Pharmaceuticals, Inc., and Chief Medical Officer at inVentiv Clinical Solutions LLC.
He also worked as the Head-Central Nervous System Therapeutic Area at Sandoz Research Institute.
Dr. Henry holds a doctorate degree from The University of Chicago and an undergraduate degree from the University of Illinois.
Earl Webb Henry active positions
Companies | Position | Start |
---|---|---|
H2O Clinical LLC
H2O Clinical LLC Medical/Nursing ServicesHealth Services H2O Clinical LLC provides health care and social assistance. The company was founded on January 24, 2016 and is headquartered in Hunt Valley, MD. | Chief Tech/Sci/R&D Officer | 31/05/2011 |
Firma Clinical Research LLC
Firma Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Firma Clinical Research LLC provides contract research and clinical research services to enable drug development. It offers data collection, data management, medical writing, patient recruitment, biostatistics, clinical pharmacology, clinical consulting, and patient retention services. The company is headquartered in Chicago, IL. | Chief Tech/Sci/R&D Officer | - |
Former positions of Earl Webb Henry
Companies | Position | End |
---|---|---|
inVentiv Clinical Solutions LLC | Chief Tech/Sci/R&D Officer | 31/05/2011 |
HHI Clinical & Statistical Research Services LLC
HHI Clinical & Statistical Research Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., HHI Clinical & Statistical Research Services LLC is a company that provides statistical analysis and data management to the pharmaceutical industry. The company is based in Baltimore, MD. HHI Clinical & Statistical Research Services was acquired by Ventiv Health, Inc. on November 22, 2004. | Chief Tech/Sci/R&D Officer | 31/12/2003 |
Pfizer Central Research | Chief Tech/Sci/R&D Officer | - |
Sandoz Research Institute | Corporate Officer/Principal | - |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Chief Tech/Sci/R&D Officer | - |
Training of Earl Webb Henry
The University of Chicago | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REPLIGEN CORPORATION | Health Technology |
Private companies | 8 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
HHI Clinical & Statistical Research Services LLC
HHI Clinical & Statistical Research Services LLC Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., HHI Clinical & Statistical Research Services LLC is a company that provides statistical analysis and data management to the pharmaceutical industry. The company is based in Baltimore, MD. HHI Clinical & Statistical Research Services was acquired by Ventiv Health, Inc. on November 22, 2004. | Commercial Services |
Pfizer Central Research | |
inVentiv Clinical Solutions LLC | |
Sandoz Research Institute | |
H2O Clinical LLC
H2O Clinical LLC Medical/Nursing ServicesHealth Services H2O Clinical LLC provides health care and social assistance. The company was founded on January 24, 2016 and is headquartered in Hunt Valley, MD. | Health Services |
Firma Clinical Research LLC
Firma Clinical Research LLC Miscellaneous Commercial ServicesCommercial Services Firma Clinical Research LLC provides contract research and clinical research services to enable drug development. It offers data collection, data management, medical writing, patient recruitment, biostatistics, clinical pharmacology, clinical consulting, and patient retention services. The company is headquartered in Chicago, IL. | Commercial Services |
- Stock Market
- Insiders
- Earl Webb Henry